title: Offspring of mothers fed a high fat diet display hepatic cell cycle inhibition and associated changes in gene expression and DNA methylation.
abstract: The association between an adverse early life environment and increased susceptibility to later-life metabolic disorders such as obesity, type 2 diabetes and cardiovascular disease is described by the developmental origins of health and disease hypothesis. Employing a rat model of maternal high fat (MHF) nutrition, we recently reported that offspring born to MHF mothers are small at birth and develop a postnatal phenotype that closely resembles that of the human metabolic syndrome. Livers of offspring born to MHF mothers also display a fatty phenotype reflecting hepatic steatosis and characteristics of non-alcoholic fatty liver disease. In the present study we hypothesised that a MHF diet leads to altered regulation of liver development in offspring; a derangement that may be detectable during early postnatal life. Livers were collected at postnatal days 2 (P2) and 27 (P27) from male offspring of control and MHF mothers (n = 8 per group). Cell cycle dynamics, measured by flow cytometry, revealed significant G0/G1 arrest in the livers of P2 offspring born to MHF mothers, associated with an increased expression of the hepatic cell cycle inhibitor Cdkn1a. In P2 livers, Cdkn1a was hypomethylated at specific CpG dinucleotides and first exon in offspring of MHF mothers and was shown to correlate with a demonstrable increase in mRNA expression levels. These modifications at P2 preceded observable reductions in liver weight and liver∶brain weight ratio at P27, but there were no persistent changes in cell cycle dynamics or DNA methylation in MHF offspring at this time. Since Cdkn1a up-regulation has been associated with hepatocyte growth in pathologic states, our data may be suggestive of early hepatic dysfunction in neonates born to high fat fed mothers. It is likely that these offspring are predisposed to long-term hepatic dysfunction.
authors.affiliation: Liggins Institute and the National Research Centre for Growth and Development, University of Auckland, Auckland, New Zealand.
authors.forename: Kevin J
authors.initials: KJ
authors.lastname: Dudley
authors.forename: Deborah M
authors.initials: DM
authors.lastname: Sloboda
authors.forename: Kristin L
authors.initials: KL
authors.lastname: Connor
authors.forename: Jacques
authors.initials: J
authors.lastname: Beltrand
authors.forename: Mark H
authors.initials: MH
authors.lastname: Vickers
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D002453:Cell Cycle / Q000502:physiology*; D019175:DNA Methylation / Q000235:genetics*; D004041:Dietary Fats / Q000009:adverse effects*; D005234:Fatty Liver / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D005260:Female; D005434:Flow Cytometry; D008099:Liver / Q000378:metabolism* / Q000473:pathology*; D008297:Male; D065626:Non-alcoholic Fatty Liver Disease; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D051381:Rats
chemical_list: D004041:Dietary Fats